Physician profile
Robert A Dickstein
NPI 1164537627
$862.27
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.30 · 2020: $99.04 · 2021: $137 · 2022: $136 · 2023: $153 · 2024: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387 · Education: $45.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.40 |
| Education | $45.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $230.79 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $158.70 | 2019-2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $107.15 | 2019-2021 | |
| Boston Scientific Corporation | $75.59 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $53.22 | 2020-2021 | |
| Endologix LLC | $49.67 | 2024 | Afx2 Bifurcated Endograft System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.14 | 2020-2021 | |
| Shockwave Medical, INC | $28.24 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $21.73 | 2021 | |
| Medtronic Vascular, INC. | $21.52 | 2020 | |
| Surmodics, INC. | $19.56 | 2023 | Pounce Thrombectomy, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| E.R. Squibb & Sons, L.L.C. | $17.57 | 2022 | |
| Medtronic, INC. | $15.27 | 2022 | |
| Philips North America LLC | $15.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dickstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.